Reuters |
Novartis seeks European approval of cell therapy Kymriah
Reuters ZURICH (Reuters) - Swiss drugmaker Novartis said on Monday it submitted an application for its cell therapy Kymriah to be approved in Europe for two forms of blood cancer. Swiss drugmaker Novartis' logo is seen at the company's plant in the northern ... |
Reuters |
Novartis seeks European approval of cell therapy Kymriah
Reuters ZURICH (Reuters) - Swiss drugmaker Novartis said on Monday it submitted an application for its cell therapy Kymriah to be approved in Europe for two forms of blood cancer. Swiss drugmaker Novartis' logo is seen at the company's plant in the northern ... |
Reuters |
Novartis seeks European approval of cell therapy Kymriah
Reuters ZURICH (Reuters) - Swiss drugmaker Novartis said on Monday it submitted an application for its cell therapy Kymriah to be approved in Europe for two forms of blood cancer. Swiss drugmaker Novartis' logo is seen at the company's plant in the northern ... |
News-Medical.net |
Bulgaria reports two more outbreaks of virulent bird flu
Reuters SOFIA (Reuters) - A virulent bird flu virus has spread to two more regions in Bulgaria prompting veterinary authorities to announce a cull of nearly 8,000 ducks, the Balkan country's food safety agency said on Sunday. “A total of four outbreaks of bird ... Bulgaria reports outbreaks of bird flu (avian influenza) Four outbreaks of avian flu have been detected so far on the territory of Bulgaria |
HuffPost |
A Controversial Experiment Upends The Conventional Wisdom On Heart Stents
HuffPost In addition to its finding on stents, the test showed the importance of the placebo effect. By Anna Almendrala. 120. A groundbreaking new experiment reveals that stents, which are mesh wire tubes inserted into narrow or weak arteries to widen them and ... 'Unbelievable': Heart Stents Fail to Ease Chest Pain Do Heart Stents Work? What You Need to Know A disturbing new study shows thousands of heart patients may be getting stents for no reason |